Centre for Research into Cancer Prevention and Screening, University of Dundee, Ninewells Hospital and Medical School, Dundee DD1 9SY, Scotland, UK.
NHS Bowel Cancer Screening Programme, Southern Hub, Royal Surrey County Hospital NHS Foundation Trust, Guildford, Surrey, UK.
Clin Chem Lab Med. 2019 Apr 24;57(5):611-616. doi: 10.1515/cclm-2018-0464.
Faecal immunochemical tests for haemoglobin (FIT) are widely used in asymptomatic population screening for colorectal (bowel) cancer. FIT are also used to assist with the assessment of patients presenting with lower abdominal symptoms. Quantitative FIT allow the generation of numerical estimates of faecal haemoglobin (f-Hb) concentrations. There is now great interest in "low" f-Hb concentrations in these clinical settings: in consequence, knowledge of the detection capability is very important for f-Hb concentration examinations. There are a number of current problems associated with the reporting of low f-Hb concentrations and wide misunderstanding of the metrological aspects of examinations of f-Hb at low concentrations. These would be solved if the detectability characteristics of f-Hb concentration examinations, namely, the limit of blank (LoB), limit of detection (LoD) and limit of quantitation (LoQ), were generated, validated and used in reporting systems exactly as recommended in the EP17-A2 guideline of the Clinical Laboratory Standards Institute. LoB and LoD are statistical concepts, but the LoQ depends on definition of analytical performance specifications (APS). In this Opinion Paper proposals for interim APS are made, based on the current state of the art achieved with examinations of faecal samples. It is proposed that LoQ is determined at an examination imprecision of CV≤10% using faecal samples naturally positive for Hb rather than faeces spiked with haemolysate. Detailed proposals for reporting f-Hb data at low concentrations are also made.
粪便免疫化学检测血红蛋白(FIT)广泛应用于无症状人群的结直肠癌(肠道)筛查。FIT 也用于协助评估出现下腹部症状的患者。定量 FIT 可生成粪便血红蛋白(f-Hb)浓度的数值估计。目前,人们对这些临床环境中的“低”f-Hb 浓度非常感兴趣:因此,了解检测能力对于 f-Hb 浓度检测非常重要。目前,与低 f-Hb 浓度报告相关的问题有很多,并且对低浓度 f-Hb 检测的计量学方面存在广泛的误解。如果按照临床实验室标准协会 EP17-A2 指南中的建议,准确地在报告系统中生成、验证和使用 f-Hb 浓度检测的可检测特性(LoB、LoD 和 LoQ),就可以解决这些问题。LoB 和 LoD 是统计概念,但 LoQ 取决于分析性能规格(APS)的定义。在本意见书中,基于目前在粪便样本检测方面取得的最新技术水平,提出了临时 APS 的建议。建议在使用自然含有 Hb 的粪便样本而不是用溶血物处理的粪便样本,在 CV≤10%的检测精密度下确定 LoQ。还提出了详细的低浓度 f-Hb 数据报告建议。